Trial intelligence / Profile preview

Antistax Efficacy in Chronic Venous Insufficiency

NCT02191163Phase 2Completed

Sponsor
Boehringer Ingelheim
Start
Apr 2002
Primary completion
Aug 2002
Modality
Small Molecules
01

Overview

A Phase 2 trial of Red vine leaf extract in chronic venous insufficiency (CVI), sponsored by Boehringer Ingelheim. Started Apr 2002; status: completed.

02

Drugs

Red vine leaf extract
03

Conditions

chronic venous insufficiency (CVI)

Beyond the preview

Go deeper on NCT02191163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02191163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call